10.3 Antiparasitic Drugs and Mechanisms of Action

Antiparasitic drugs are crucial weapons against parasitic infections. They target different types of parasites, from protozoa to worms, using various mechanisms. Understanding how these drugs work helps us choose the right treatment for specific parasites and improve patient outcomes.

These medications can have side effects and interactions, so it's important to use them carefully. Factors like drug absorption, metabolism, and elimination affect how well they work. Knowing these details helps healthcare providers tailor treatments to each patient's needs and minimize risks.

Antiparasitic Drug Classification

Antiprotozoal Drugs

Top images from around the web for Antiprotozoal Drugs

• 

  Frontiers | Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular ... View original

  Is this image relevant?

• 

  Frontiers | Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs ... View original

  Is this image relevant?

• 

  Frontiers | Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular ... View original

  Is this image relevant?

• 

  Frontiers | Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs ... View original

  Is this image relevant?

1 of 2

Top images from around the web for Antiprotozoal Drugs

• 

  Frontiers | Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular ... View original

  Is this image relevant?

• 

  Frontiers | Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs ... View original

  Is this image relevant?

• 

  Frontiers | Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular ... View original

  Is this image relevant?

• 

  Frontiers | Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs ... View original

  Is this image relevant?

1 of 2

• Target protozoan parasites
• Include nitroimidazoles (metronidazole, tinidazole), quinolines (chloroquine, primaquine), and antifolates (pyrimethamine, sulfadoxine)
• Nitroimidazoles are effective against anaerobic protozoa and bacteria, such as Giardia, Trichomonas, and Entamoeba
• Quinolines are primarily used to treat malaria caused by Plasmodium species
• Antifolates disrupt the folate pathway, making them useful against malaria and toxoplasmosis

Antihelminthic Drugs

• Target helminths (worms)
• Include benzimidazoles (albendazole, mebendazole), macrocyclic lactones (ivermectin), praziquantel, and pyrantel pamoate
• Benzimidazoles are broad-spectrum antihelminthics used to treat roundworm, pinworm, and hookworm infections
• Macrocyclic lactones, such as ivermectin, are effective against roundworms, threadworms, and river blindness caused by Onchocerca volvulus
• Praziquantel is the drug of choice for treating schistosomiasis and tapeworm infections
• Pyrantel pamoate is used to treat pinworm, roundworm, and hookworm infections

Specific Target Organism Classification

• Antimalarials (chloroquine, artemisinin) target Plasmodium species that cause malaria
• Antischistosomals (praziquantel) are used to treat schistosomiasis caused by Schistosoma species
• Antileishmanials (amphotericin B, miltefosine) are effective against Leishmania species that cause leishmaniasis
• Antitrypanosomals (nifurtimox, benznidazole) target Trypanosoma species responsible for Chagas disease and sleeping sickness

Mechanisms of Antiparasitic Action

Nucleic Acid Synthesis Inhibition

• Nitroimidazoles (metronidazole, tinidazole) inhibit nucleic acid synthesis by damaging DNA and causing strand breaks, leading to cell death in anaerobic protozoa and bacteria
• Antifolates (pyrimethamine, sulfadoxine) disrupt the folate pathway by inhibiting dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS), respectively, impairing nucleic acid synthesis and parasite growth
• Inhibition of nucleic acid synthesis prevents parasite replication and survival

Interference with Parasite Metabolism

• Quinolines (chloroquine, primaquine) interfere with the parasite's ability to detoxify heme, leading to the accumulation of toxic heme products and parasite death
• Heme detoxification is essential for the survival of blood-feeding parasites, such as Plasmodium
• Accumulation of toxic heme products causes oxidative stress and damage to parasite membranes and proteins

Disruption of Parasite Cytoskeleton and Motility

• Benzimidazoles (albendazole, mebendazole) bind to β-tubulin, inhibiting microtubule polymerization and impairing parasite motility, glucose uptake, and cell division
• Microtubules are essential for parasite movement, nutrient uptake, and cell division
• Disruption of the parasite cytoskeleton leads to paralysis and death

Alteration of Parasite Neuromuscular Function

• Macrocyclic lactones (ivermectin) enhance the activity of glutamate-gated chloride channels, leading to hyperpolarization of nerve and muscle cells, causing paralysis and death of the parasite
• Glutamate-gated chloride channels are specific to invertebrates and are not present in mammals, making macrocyclic lactones selective for parasites
• Hyperpolarization of nerve and muscle cells impairs parasite movement and feeding, leading to paralysis and death

Increased Permeability of Parasite Membranes

• Praziquantel increases the permeability of helminth cell membranes to calcium ions, causing muscle contraction, paralysis, and tegumental damage
• Calcium influx disrupts the normal function of helminth muscle cells and causes sustained contraction and paralysis
• Tegumental damage exposes the parasite to the host immune system and facilitates its elimination

Pharmacokinetics and Pharmacodynamics of Antiparasitic Drugs

Absorption and Distribution

• Antiparasitic drugs can be administered orally, parenterally, or topically
• Factors affecting absorption include the drug's solubility, stability, and the presence of food in the gastrointestinal tract
• Lipophilic drugs, such as ivermectin, have a high volume of distribution and can persist in the body for extended periods
• Plasma protein binding and affinity for specific tissues influence drug distribution

Metabolism and Excretion

• Many antiparasitic drugs undergo hepatic metabolism via cytochrome P450 enzymes
• Genetic variations in cytochrome P450 enzymes can affect drug metabolism and efficacy
• Antiparasitic drugs are primarily eliminated through renal or hepatic routes
• Renal impairment or hepatic dysfunction can affect drug elimination and may require dose adjustments

Pharmacodynamic Considerations

• Efficacy depends on achieving sufficient drug concentrations at the site of action and maintaining these concentrations for an adequate duration
• Factors such as drug resistance, host immune response, and parasite burden can influence the pharmacodynamic response
• Combination therapy with drugs having different mechanisms of action can improve efficacy and reduce the risk of resistance development
• Monitoring drug levels and parasite response is important for optimizing treatment outcomes

Side Effects and Contraindications of Antiparasitic Medications

Common Side Effects

• Gastrointestinal disturbances (nausea, vomiting, diarrhea)
• Headache and dizziness
• Skin rash and pruritus
• Transient elevation of liver enzymes
• Hematological abnormalities, such as anemia or thrombocytopenia

Severe Adverse Reactions

• Neurotoxicity, including seizures, encephalopathy, and peripheral neuropathy
• Hepatotoxicity, ranging from mild transaminase elevations to severe hepatitis
• Bone marrow suppression, leading to pancytopenia
• Severe cutaneous adverse reactions, such as Stevens-Johnson syndrome or toxic epidermal necrolysis
• Close monitoring and prompt intervention are necessary for managing severe adverse reactions

Drug Interactions

• Interactions can occur between antiparasitic agents and other medications, such as antiepileptics, anticoagulants, and immunosuppressants
• Cytochrome P450 inhibitors or inducers can alter the metabolism of antiparasitic drugs, requiring dose adjustments
• Concomitant use of antiparasitic drugs with other QT-prolonging agents may increase the risk of cardiac arrhythmias
• Careful review of patient medications and potential interactions is crucial for safe and effective antiparasitic therapy

Contraindications and Precautions

• Some antiparasitic drugs are contraindicated in pregnancy due to potential teratogenic effects
• Benzimidazoles should be avoided during the first trimester, and quinolines are generally contraindicated throughout pregnancy
• Antiparasitic drugs may be contraindicated in patients with severe hepatic or renal impairment
• Hypersensitivity to the drug or its components is a contraindication to therapy
• Precautions may be necessary for patients with pre-existing conditions, such as seizure disorders or cardiac conduction abnormalities